Delivery Order SPE2DR25D3008-SPE2DR26F3P7B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 17, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,274.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 23, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of February 13, 2026. This is a competitively awarded contract with no set-aside designation, and performance will take place at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,111.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 6, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award was made on a non-set-aside, competitive basis and represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $6,370.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by February 5, 2026. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a task order against AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,822.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 18, 2026. The products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,233.70 to Amerisourcebergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was awarded on January 28, 2026, with an ultimate completion date of February 19, 2026, and employs firm fixed-price pricing with no set-aside designation. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,959.75 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitive delivery order with an ultimate completion date of January 9, 2026, and no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a routine...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,822.30 on January 27, 2026, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 18, 2026, to be performed at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $183,470.40 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on January 20, 2026, with an ultimate completion date of February 10, 2026. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,111.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on December 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This award was...
- SPE2DR25D3008Indefinite Delivery Contract
- SPE2DR25D3008-SPE2DR26F3P7BDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.10 to Amerisourcebergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract, issued on January 27, 2026, has an ultimate completion date of February 18, 2026, and represents a non-competitive set-aside award. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp operates as a child entity under its parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor and healthcare solutions provider serving federal military and veteran healthcare systems. This delivery order is issued under Amerisourcebergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and related supplies to support military healthcare programs worldwide. The parent company, Cencora, Inc., also maintains a larger IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, further supporting the company's role as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/26/26 |